United Kingdom · 
Who invested in Kesmalea Therapeutics?
Kesmalea Therapeutics's investors include Oxford Science Enterprises and BioInnovation Institute.
United Kingdom · Series A startup
Who invested in Kesmalea Therapeutics
Funding summaryUpdated 26 Oct 2026
$6.0Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $6.0MJan 2023
- Investors
- 2
The rounds
- Jan 2023
Founders and team
From Kesmalea Therapeutics's own website: 1 founder, 8 on the team.
Everyone who backed them
BioInnovation InstituteVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Kesmalea Therapeutics
How much has Kesmalea Therapeutics raised?
Kesmalea Therapeutics has raised $6.0M across 1 round since 2023.
When did Kesmalea Therapeutics last raise?
Kesmalea Therapeutics's most recent round was a Series A of $6.0M in Jan 2023.
What was Kesmalea Therapeutics's biggest round?
Its most recent round, $6.0M in Jan 2023, is also its largest on record.
Who backed Kesmalea Therapeutics first?
Kesmalea Therapeutics's first round on record, in Jan 2023, was backed by Oxford Science Enterprises and BioInnovation Institute.
What stage is Kesmalea Therapeutics at?
Kesmalea Therapeutics's latest named round is a Series A, in Jan 2023.
Where is Kesmalea Therapeutics based?
Kesmalea Therapeutics is based in the United Kingdom.
Companies like Kesmalea Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.